Aims: To compare the basal plasma reproductive hormonal profile in three groups of athletes involved in different training programs, and to define the relationship between androgen level and bone mineral density (BMD) in male athletes. Methods: Basal serum total testosterone (TT), free androgen index (FAI), sex hormone-binding globulin (SHBG), cortisol, cortisol to TT ratio, luteinizing hormone (LH), estrogen and BMD were evaluated in cyclists (CY; n = 11), triathletes (TR; n = 14) and swimmers (SW; n = 13) and compared with less active controls (n = 10). Results: TT and FAI levels were lower (p < 0.05) in CY and TR, whereas the ratio of cortisol to TT was increased in CY only (p < 0.05). No alteration in serum LH, SHBG, estrogen or cortisol concentration was observed. BMD was higher in the proximal femur in TR (p < 0.05). No BMD or hormonal differences were found in SW. Conclusion: Only the endurance training of CY and TR induced androgen deficiency without apparent alteration of BMD.

Keywords:
Testosterone, Endurance athletes, Bone mineral density, Body composition, Physical activity
1.
Gray A, Feldman HA, McKinlay JB, Longcope C: Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts male aging study. J Clin Endocrinol Metab 1991;73:1016–1025.
2.
Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ: Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989;69:523–527.
3.
Seeman E, Melton LJ: Risk factors for osteoporosis in men. Am J Med 1983;75:977–983.
4.
Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF Jr: Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1987;106:354–361.
5.
Tenover JS: Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992;75:1092–1098.
6.
Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santana J, Loh L, Lenrow AA, Holmes JH, Kapoor SC, Atkinson LE, Strom BL: Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000;85:2670–2677.
7.
Colvard DS, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs BL, Spelsberg TC: Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 1989;86:854–857.
8.
Mizuno Y, Hosoi T, Inoue S, Ikegami A, Kaneki M, Akedo Y, Nakamura T, Ouchi Y, Chan C, Orimo H: Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells. Calcif Tissue Int 1994;54:325–329.
9.
Abraham SF, Beaumont PJV, Fraser IS: Body weight, exercise, and menstrual status among ballet dancers in training. Br J Obstet Gynaecol 1982;89:507–510.
10.
Rencken ML, Chesnut CH, Drinkwater BL: Bone density at multiple skeletal sites in amenorrheic athletes. JAMA 1996;276:238–240.
11.
Cann CE, Martin MC, Genant HK, Jaffe RB: Decreased spinal mineral content in amenorrheic women. JAMA 1984;251:626–629.
12.
Robinson TL, Snow-Harter C, Taffe D, Gillis D, Shaw J, Marcus R: Gymnasts exhibit higher bone mass than runners despite similar prevalence of amenorrhea and oligomenorrhea. J Bone Miner Res 1995;10:26–35.
13.
Otis CL: Exercise-associated amenorrhea. Clin Sports Med 1992;11:351–362.
14.
Galbo H, Hummer L, Petersen IB, Christiensen NJ, Bie N: Thyroid and testicular responses to graded and prolonged exercise in man. Eur J Appl Physiol 1977;36:101–106.
15.
Cumming DC, Brunsting LA 3rd, Strich G, Ries AL, Rebar RW: Reproductive hormone increases in response to acute exercise in men. Med Sci Sports Exerc 1986;18:369–373.
16.
Hakkinen K, Pakarinen A: Acute hormonal responses to two different fatiguing heavy-resistance protocols in male athletes. J Appl Physiol 1993;74:882–887.
17.
Fahrner CL, Hackney AC: Effects of endurance exercise on free testosterone concentration and the binding affinity of sex hormone binding globulin (SHBG). Int J Sports Med 1998;19:12–15.
18.
Hackney AC, Sinning WE, Bruot BC: Reproductive hormonal profiles of endurance-trained and untrained males. Med Sci Sports Exerc 1988;20:60–65.
19.
Cumming DC, Wheeler GD, McColl EM: The effect of exercise on reproductive function in men. Sports Med 1989;7:1–17.
20.
Wheeler GD, Singh M, Pierce WD, Epling WF, Cumming DC: Endurance training decreases serum testosterone levels in men without change in luteinizing hormone pulsatile release. J Clin Endocrinol Metab 1991;72:422–425.
21.
De Souza MJ, Arce JC, Pescatello LS, Sherzer HS, Luciano A: Gonadal hormones and semen quality in male runners. Int J Sports Med 1994;15:383–391.
22.
Smith R, Rutherford OM: Spine and total bone mineral density and serum testosterone levels in male athletes. Eur J Appl Physiol Occup Physiol 1993;67:330–334.
23.
MacConnie SE, Barkan A, Lampman RM, Schork MA, Beitins IZ: Decreased hypothalamic gonadotropin-releasing hormone secretion in male marathon runners. N Engl J Med 1986;315:411–417.
24.
Bagatell CJ, Bremner WJ: Sperm counts and reproductive hormones in male marathoners and lean controls. Fertil Steril 1990;53:688–692.
25.
Lucia A, Chicharro JL, Perez M, Serratosa L, Bandres F, Legido JC: Reproductive function in male endurance athletes: Sperm analysis and hormonal profile. J Appl Physiol 1996;81:2627–2636.
26.
Adlercreutz HM, Harkonen M, Kuoppasami K, Naveri H, Huhtaniemi I, Tikkanen H, Remes K, Dessypris A, Karvonen J: Effect of training on plasma anabolic and catabolic steroid hormones and their response during physical exercise. Int J Sports Med 1986;7 (suppl 1):27–28.
27.
MacDougall JD, Webber CE, Martin J, Ormerod S, Chesley A, Younglai EV, Gordon L, Blimkie CJR: Relationship among running mileage, bone density, and serum testosterone in male runners. J Appl Physiol 1992;73:1165–1170.
28.
Grimston S, Willows ND, Hanley DA: Mechanical loading regime and its relationship to bone mineral density in children. Med Sci Sports Exerc 1993;25:1203–1210.
29.
Fardellone P, Sebert JL, Bouraya M, Bonidan O, Leclercq G, Doutrellot C, Bellony R, Dubreuil A: Evaluation de la teneur en calcium du régime alimentaire par auto-questionnaire fréquentiel. Rev Rhum 1991;58:99–103.
30.
Greighton DL, Morgan AL, Boardley D, Brolinson G: Weight-bearing exercise and markers of bone turnover in female athletes. J Appl Physiol 2001;90:565–570.
31.
Hoogeveen AR, Zonderland ML: Relationships between testosterone, cortisol and performance in professional cyclists. Int J Sports Med 1996;17:423–428.
32.
Hakkinen K, Keskinen KL, Alen M, Komi PV, Kauhanen H: Serum hormone concentrations during prolonged training in elite endurance-trained and strength-trained athletes. Eur J Appl Occup Physiol 1989;59:233–238.
33.
Flynn MG, Pizza FX, Boone JB, Andres FF, Michaud TA, Rodriguez-Zayas JR: Indices of training stress during competitive running and swimming seasons. Int J Sports Med 1994;15:21–26.
34.
Mujika I, Chatard JC, Padilla S, Guezennec CY, Geyssant A: Hormonal responses to training and its tapering off in competitive swimmers: Relationships with performance. Eur J Appl Physiol Occup Physiol 1996;74:361–366.
35.
Tyndall GL, Kobe RW, Houmard JA: Cortisol, testosterone, and insulin action during intense swimming training in humans. Eur J Appl Physiol Occup Physiol 1996;73:61–65.
36.
Cumming DC, Quigley ME, Yen SSC: Acute suppression of circulating testosterone levels by cortisol in men. J Clin Endocrinol Metab 1983;57:671–673.
37.
Ding JH, Sheckter CB, Drinkwater BL, Soules MR, Bremmer WJ: High serum cortisol levels in exercise-associated amenorrhea. Ann Intern Med 1988;108:530–534.
38.
Roberts AC, McClure RD, Weiner RI, Brooks GA: Overtraining affects male reproductive status. Fertil Steril 1993;60:686–692.
39.
McGrady AV: Effects of psychological stress on male reproduction: A review. Arch Androl 1984;13:1–7.
40.
Legros P: Le surentraînement: Diagnostic des manifestations psychocomportementales précoces. Sci Sports 1994;8:71–74.
41.
Bilamin JE, Blanchard MS, Russek-Cohen E: Lower vertebral bone density in male long distance runners. Med Sci Sports Exerc 1989;21:66–70.
42.
Hetland ML, Haarbo J, Christiansen C: Low bone mass and high bone turnover in male long distance runners. J Clin Endocrinol Metab 1993;77:770–775.
43.
Nilsson J, Thorstensson A: Ground reaction forces at different speeds of human walking and running. Acta Physiol Scand 1989;136:217–227.
44.
Vanderschueren D, Bouillon R: Androgens and bone. Calcif Tissue Int 1995;56:341–346.
45.
Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Piaseu N, Chailurkit L: Serum oestradiol and oestrogen-receptor gene polymorphisms are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol (Oxf) 1998;49:803–809.
46.
Smith EP, Boyd J, Frank RG, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS: Estrogen resistance caused by mutation in the estrogen-receptor gene in man. N Engl J Med 1994;16:1056–1061.
47.
Foresta C, Busnardo B, Ruzza G, Zanetta G, Mioni R: Lower calcitonin levels in young hypogonadic men with osteoporosis. Horm Metab Res 1983;15:206–207.
48.
Marie PJ, Hott M, Durand D: Somatostatin infusion inhibits the stimulatory effect of testosterone on endosteal bone formation in the mouse. Metabolism 1988;37:429–435.
49.
Griggs RC, Kingston W, Jozefowics RF, Herr BE, Forbes G, Halliday D: Effect of testosterone on muscle mass and protein synthesis. J Appl Physiol 1989;66:498–503.
50.
Xu X, De Pergola G, Bjorntorp P: The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology 1990;126:1229–1234.
51.
Seidell JC, Bjorntorp P, Sjostrom L, Kvist H, Sannerstedt R: Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990;39:897–901.
52.
Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A: Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996;81:4358–4365.
53.
Mauras N, Hayes V, Welch S, Rini I, Helgeson K, Dokler M, Veldhuis JD, Urban RJ: Testosterone deficiency in young men: Marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 1998;83:1886–1892.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.